Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC.
Holger HebartMichael KiehlJiri TomasekTibor CsősziReija KoukakisGeorge KafatosAnja KuhnKatja BjorklofGaston DemontyTomas BuchlerPublished in: Advances in therapy (2019)
Amgen.